James is a senior foreign attorney at Shin & Kim whose practice captures a diverse range of cross-border transactions including cross-border M&A, investments and international capital markets transactions.

James has advised Korean and global private equity firms, Korean conglomerates and listed Korean companies with their cross-border transactions across the Asia-Pacific region with a Korean and/or Australian nexus.

James is a commercially astute lawyer holding a B.Com.(Accounting) as well as an LL.B. from the University of Sydney, who considers the client’s commercial objectives as a top priority in providing his legal services.

• Advised Kyobo Life on its joint venture agreement with AXA-IM.
• Advised OTPP on its co-investment with MBK Partners in the acquisition of Medit.
• Advised a founder and Levit Inc. on a Series B preferred stock issuance transaction.
• Advised majority shareholders, Line Friends and IPX Corporation, on a Series A preferred stock issuance transaction.
• Advised KakaoPay on the takeover of a U.S. listed company.
• Advised on investment in EMR Capital’s UK mining assets for Meritz Securities.
• Advised Handsome Corp. on the pre-IPO investment in Lanvin Group (now listed on NYSE).
• Advised Meritz Securities on the equity investment in Fosun International prior to IPO of Lanvin Group (now listed on NYSE).
• Advised Bricks Capital Management on the investment in Series B issued by a U.S. battery company.
• Advised Hanwha Impact on the investment in Ark Energy, an Australian-based renewable power project company owned by Korea Zinc.
• Advised Anchor Equity Partners on the JV establishment with L`Oreal and Shilla Hotels to promote a new cosmetics brand.
• Advised Skylake PE on the sale of its 100% equity interest in NexFlex, Co., Ltd.
• Advised Dunamu & Partners on the investment in Series B preferred stocks issued by a U.S. company, Genome Insight, Inc.
• Represented and advised Woori Global Asset Management on the acquisition of convertible bonds issued by a U.S. company.
• Advised the owner of Classys Inc., a KOSDAQ-listed company, on the sale of its shares with management rights to Bain Capital at approximately KRW 670 billion.
• Advised Carlyle Group on the acquisition of 10% of Hyundai Glovis Co., Ltd. from its majority shareholder in an off-hours block trade for approximately KRW 600 billion.
• Advised on the investment in a Southeast Asian online shopping platform (Carousell) through a special situation fund (SSF) managed by STIC Investment.
• Advised Easy Holdings Co., Ltd. on the acquisition of 100% of the equity interest in U.S.-based Furst-McNess Company in a cash-out reverse triangular merger.
• Represented Mad for Garlic in the acquisition of TGI Friday's franchise operations from Lotte.
• Advised the Skinfactory in the sale of 100% of its equity interest in the VIG Fund.
• Advised KNW Co., Ltd. on the buyout of Solvay Korea (currently Fluorine Korea), a KOSDAQ-listed company.
• Advised TPG on the acquisition of Health Balance.
• Advised Pan Ocean Co., Ltd. on the acquisition of a 36.25% minority interest in EGT in Washington, U.S.
• Advised IMM Investment on the pre-IPO investment in the data center in China (Chindata Group, currently listed on NASDAQ) with SK Holdings.
• Advised on the investment in Series H issued by Singapore-based Grab for PEF managed by STIC Investment.
• Advised Big Hit Entertainment (currently Hive) on the acquisition of Pledis Entertainment.
• Advised SeAH Besteel on the acquisition of Arconic Korea.
• Advised CJ CGV on the sale of a 28% minority interest in CGI Holdings Limited, a Hong Kong subsidiary of CJ CGV, to MBK Partners.